Publicaciones en las que colabora con Aránzazu González Miqueo (11)

2024

  1. Circulating biomarkers of myocardial remodelling: current developments and clinical applications

    Heart, Vol. 110, Núm. 19, pp. 1157-1163

  2. Effects of spironolactone on exercise blood pressure in patients at increased risk of developing heart failure: report from the HOMAGE trial

    Hypertension Research

  3. Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management

    Hypertension, Vol. 81, Núm. 2, pp. 218-228

  4. Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact

    Matrix Biology, Vol. 134, pp. 1-22

  5. Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

    Heart, Vol. 110, Núm. 19, pp. 1180-1187

2023

  1. Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies

    Molecular Aspects of Medicine, Vol. 93

  2. Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study

    Circulation: Heart Failure, Vol. 16, Núm. 5, pp. E009694

2021

  1. Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches

    Nature Reviews Cardiology, Vol. 18, Núm. 7, pp. 479-498

2019

  1. Characterization of biventricular alterations in myocardial (reverse) remodelling in aortic banding-induced chronic pressure overload

    Scientific Reports, Vol. 9, Núm. 1

2005

  1. Avances en el diagnóstico de la cardiopatía hipertensiva

    Hipertensión y riesgo vascular, Vol. 22, Núm. 6, pp. 259-265

2001

  1. Marcadores bioquímicos de fibrosis miocárdica en las enfermedades cardíacas

    Hipertensión y Riesgo Vascular, Vol. 18, Núm. 8, pp. 383-388